Post-infectious irritable bowel syndrome

Table 1 Estimates of incidence of PI-IBS¹

Author	Study type	Control group	Type of exposure	Follow-up (mo)	Criteria for diagnosis of IBS	Mean quality assessment score	Incidence of IBS in exposed cohort	Country
McKendrick[24]	Prospective	None	Confirmed Salmonella	12	Rome I	14.5	12/38 = 31.6%	United Kingdom
Neal[13]	Prospective	None	Confirmed-bacterial GE	6	Modified Rome I	16.0	23/366 = 6.3%	United Kingdom
Gwee[22]	Prospective	None	Confirmed gastroenteritis	6	Clinical assessment	21.0	9/86 = 10.5%	United Kingdom
Gwee[28]	Prospective	None	Confirmed Shigella, Campylobacter, Salmonella	12	Rome I	21.5	22/109 = 20.2%	United Kingdom
Rodríguez[6]	Prospective	Matched from database	Confirmed bacterial GE	12	Physician diagnosis	19.0	14/318 = 4.4%	United Kingdom
Ilnyckyj[5]	Prospective	Uninfected contemporaneous	Self reported (traveler’s diarrhea)	3	Rome I	22.5	2/48 = 4.2%	Canada
Dunlop[3]	Prospective	None	Self reported (presumed Campylobacter)	3	Rome I	21.0	103/747 = 13.8%	United Kingdom
Parry[27]	Prospective Case control	Matched from database	Confirmed Campylobacter, Salmonella	3-6	Rome II	23.5	18/128 = 14.1%	United Kingdom
Wang[12]	Prospective	Uninfected family	Confirmed Shigella	12, 24	Rome II	23.5	24/295 = 8.1%	China
Okhuysen[15]	Prospective	None	Self-reported travelers’ diarrhea	6	Rome II	20.0	6/169 = 3.6%	United States
Kim[4], Ji[23], Jung[41]	Prospective	Uninfected contemporaneous	Self reported (presumed Shigella)	12, 36, 60	Modified Rome I & II	24.5	15/143 = 10.5%	South Korea
Mearin[25]	Prospective	Uninfected contemporaneous	Self reported (presumed Salmonella)	3, 6, 12	Rome II	22.5	27/467 = 5.8%	Spain
Marshall[11]	Prospective	Uninfected contemporaneous	Self reported (presumed E. coli, Campylobacter)	24-36	Rome I	26.5	417/1368 = 30.5%	Canada
Borgaonkar[21]	Prospective	None	Confirmed (any bacterial pathogen)	3	Manning & Rome I	20.0	7/191 = 3.7%	Canada
Moss-Morris[26]	Prospective	Mononucleosis	Confirmed Campylobacter	3, 6	Rome I & II	21.5	59/592 = 10.0%	New Zealand
Stermer[14]	Prospective	Uninfected contemporaneous	Self reported (travelers’ diarrhea)	6	Rome II	13.6	13/118 = 11.0%	Israel
Marshall[10]	Prospective	Uninfected contemporaneous	Self reported (presumed viral)	3, 6, 12, 24	Rome I	23.5	15/92 = 16.3%	Canada
Spence[30]	Prospective	None	Confirmed Campylobacter	3, 6	Rome I & II	24.0	63/620 = 10.2%	New Zealand

¹Thabane et al. APT 2007; 26: 535-544.